Drug Type Small molecule drug |
Synonyms LUF7930 |
Target |
Mechanism A3R modulators(Adenosine A3 receptor modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC26H26FN5O6S |
InChIKeyRQOWCEJQEPFCBG-UHFFFAOYSA-N |
CAS Registry2941609-80-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Inflammation | Discovery | NL | 02 Aug 2023 |